Join
TTAalumni: 宇康生科完成D輪募資
CategoryNews
Lecture Date:
2024-04-24
訂閱 TTA 電子報，最新活動不漏接
Subscribe to 𝗧𝗧𝗔 𝗻𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿, don’t miss any of our events
長期研發針對語音及言語障礙解決方案的新創醫材公司宇康生科，宣布成功完成共600 萬美元的D 輪募資，此輪募資由向來專注於高科技和生物技術領域的台杉投資領投，來自國家級資金加持，宇康生科期盼能加速拓展海外市場！
宇康生科創辦人暨執行長何冠旻博士表示，「我們非常高興台杉投資能夠領投我們的 D 輪融資，這使我們能夠在嗓音健康技術領域持續推動創新。這一次投資給足了我們兼負使命的信心也相信我們有改變這個市場的潛力。」
快到留言區給予他們鼓勵和道賀吧！
Innovating with Balloons to Empower the Voiceless - TTAalumni APrevent Secures $6M in Funding with Taiwania Capital
Taiwanese medical device startup APrevent announced the completion of their D-round fundraising on April 2nd, securing $6 million. This round was led by Taiwania Capital, a company focusing on high-tech and biotechnology. APrevent aims to expand its presence in the European, North American, and Southeast Asian markets with this national-level funding.
完整新聞請見 連結 NEWS
Subscribe to 𝗧𝗧𝗔 𝗻𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿, don’t miss any of our events
長期研發針對語音及言語障礙解決方案的新創醫材公司宇康生科，宣布成功完成共600 萬美元的D 輪募資，此輪募資由向來專注於高科技和生物技術領域的台杉投資領投，來自國家級資金加持，宇康生科期盼能加速拓展海外市場！
宇康生科創辦人暨執行長何冠旻博士表示，「我們非常高興台杉投資能夠領投我們的 D 輪融資，這使我們能夠在嗓音健康技術領域持續推動創新。這一次投資給足了我們兼負使命的信心也相信我們有改變這個市場的潛力。」
快到留言區給予他們鼓勵和道賀吧！
Innovating with Balloons to Empower the Voiceless - TTAalumni APrevent Secures $6M in Funding with Taiwania Capital
Taiwanese medical device startup APrevent announced the completion of their D-round fundraising on April 2nd, securing $6 million. This round was led by Taiwania Capital, a company focusing on high-tech and biotechnology. APrevent aims to expand its presence in the European, North American, and Southeast Asian markets with this national-level funding.
完整新聞請見 連結 NEWS
